期刊
PHOTOCHEMISTRY AND PHOTOBIOLOGY
卷 88, 期 1, 页码 175-187出版社
WILEY-BLACKWELL
DOI: 10.1111/j.1751-1097.2011.01022.x
关键词
-
资金
- Open University PhD fellowship
Photodynamic therapy (PDT) is an increasingly popular anticancer treatment that uses photosensitizer, light and tissue oxygen to generate cytotoxic reactive oxygen species (ROS) within illuminated cells. Acting to counteract ROS-mediated damage are various cellular antioxidant pathways. In this study, we combined PDT with specific antioxidant inhibitors to potentiate PDT cytotoxicity in MCF-7 cancer cells. We used disulphonated aluminium phthalocyanine photosensitizer plus various combinations of the antioxidant inhibitors: diethyl-dithiocarbamate (DDC, a Cu/Zn-SOD inhibitor), 2-methoxyestradiol (2-ME, a Mn-SOD inhibitor), l-buthionine sulfoximine (BSO, a glutathione synthesis inhibitor) and 3-amino-1,2,4-triazole (3-AT, a catalase inhibitor). BSO, singly or in combination with other antioxidant inhibitors, significantly potentiated PDT cytotoxicity, corresponding with increased ROS levels and apoptosis. The greatest potentiation of cell death over PDT alone was seen when cells were preincubated for 24 h with 300 mu m BSO plus 10 mm 3-AT (1.62-fold potentiation) or 300 mu m BSO plus 1 mu m 2-ME (1.52-fold), or with a combination of all four inhibitors (300 mu m BSO, 10 mm 3-AT, 1 mu m 2-ME and 10 mu m DDC: 1.4-fold). As many of these inhibitors have already been clinically tested, this work facilitates future in vivo studies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据